| 摘要 |
The present invention relates to the compounds of the formula: <IMAGE> in which R1, R2, R3, R4, R5, R6, R7, and R8 are independently hydrogen, lower alkyl which is optionally substituted, lower alkoxy which is optionally substituted, hydroxy, acyloxy, or halogen; R9 is hydrogen, hydroxy, acyloxy, lower alkyl which is optionally substituted, lower alkoxy which is optionally substituted, or lower alkylamino which is optionally substituted; E1 is hydrogen, or an ester residue; m is an integer of from 1 to 4; or a pharmaceutically acceptable salt thereof. The compounds of the present invention exhibit phospholipase A2 inhibitory activity, and can be used in treating inflammatory conditions.
|
